Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meda AB Denies Discussions on Merger with Pharmaceutical Company


Wednesday, 5 Jun 2013 02:00am EDT 

Meda AB announced that due to speculation in the press and news media concerning Meda merging with another pharmaceutical company, it has decided to inform the market that there are currently no such discussions. Meda's policy is not to comment on speculation and will not do so in the future. This announcement is an exception to the Company's policy.